http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0672037-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 |
| filingDate | 1993-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4611674d796a125bb723aede6dbb873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60cd739f6eb91dc30bfc5638d492db70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b17347ab8f9e1485ae3490ca4cd3d47f |
| publicationDate | 1998-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0672037-B1 |
| titleOfInvention | 1,4-benzodiazepine derivatives and their use as cck-modulators |
| abstract | PCT No. PCT/EP93/03381 Sec. 371 Date Jun. 5, 1995 Sec. 102(e) Date Jun. 5, 1995 PCT Filed Dec. 2, 1993 PCT Pub. No. WO94/13648 PCT Pub. Date Jun. 23, 1994Compounds of general formula (I) <IMAGE> (I) and physiologically acceptable salts thereof; wherein R1 represents CH2CONR5R6 or CH2COR7; R2 represents a phenyl group optionally substituted by 1 or 2 substituents selected from halogen, alkyl, nitro, cyano, trifluoromethyl, trifluoromethoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, amino, substituted amino, hydroxy, alkoxy, methylenedioxy, alkoxycarbonyl, oxazolyl or oxadiazolyl; A represents a C1-4 straight or branched alkylene chain; R3 and R4 independently represent hydrogen or C1-4alkyl or R3 and R4 together with the nitrogen atom to which they are attached form a saturated 5-7 membered heterocyclic ring, which ring may contain an additional heteroatom selected from oxygen, sulphur or nitrogen; R5 represents hydrogen or C1-4alkyl; R6 represents C1-4alkyl or phenyl, optionally substituted by halogen, or R5 and R6 together with the nitrogen atom to which they are attached represent a saturated 5 to 7 membered heterocyclic ring which may be optionally substituted by 1 or 2 methyl groups or fused to a benzene ring; R7 represents a group selected from C1-4alkyl, or optionally substituted phenyl; R8 represents hydrogen or a halogen atom; n is zero, 1 or 2, are antagonists of gastrin and CCK. |
| priorityDate | 1992-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 346.